US Stock MarketDetailed Quotes

Insmed (INSM)

Watchlist
  • 94.220
  • -10.700-10.20%
Close Jun 5 16:00 ET
  • 94.290
  • +0.070+0.07%
Post 20:01 ET
20.42BMarket Cap-16.36P/E (TTM)

About Insmed Company

Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline. The company was founded in 1988 and is headquartered in Bridgewater, NJ.

Company Profile

SymbolINSM
Company NameInsmed
Listing DateJun 1, 2000
ISINUS4576693075
Founded1988
CEOMr. William H. Lewis, J.D.,M.B.A.
MarketNASDAQ
Employees1664
Fiscal Year Ends12-31
Address700 US Highway 202/206
CityBridgewater
ProvinceNew Jersey
CountryUnited States of America
Zip Code08807-3365
Phone1-908-977-9900

Company Executives

  • Name
  • Position
  • Salary
  • William H. Lewis, J.D.,M.B.A.
  • Chairman of the Board, President and Chief Executive Officer
  • 14.47M
  • Sara M. Bonstein
  • Chief Financial Officer and Principal Accounting Officer
  • 4.62M
  • S. Nicole Schaeffer
  • Chief People Strategy Officer
  • --
  • Roger Adsett
  • Chief Operating Officer
  • 4.69M
  • Michael A. Smith
  • Chief Legal Officer
  • 4.14M
  • Dr. Martina Flammer, M.B.A.
  • Chief Medical Officer
  • 4.72M
  • Elizabeth McKee Anderson, M.B.A.
  • Independent Director
  • 432.86K
  • Carol A. Schafer
  • Independent Director
  • 427.50K
  • Leo Lee
  • Independent Director
  • 425.00K
  • David R. Brennan
  • Lead Independent Director
  • 465.00K
  • Dr. Melvin Sharoky,M.D.
  • Independent Director
  • 425.00K
  • Dr. Clarissa Desjardins, PhD
  • Independent Director
  • 425.00K
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On June 3, Eastern Time, the U.S. House of Representatives passed a resolution limiting Trump's authority to use military force against Iran Show More